Evidence map›Paper›PMID 29151149›Full record

ArticleChromosoma2018

Impact of Xist RNA on chromatin modifications and transcriptional silencing maintenance at different stages of imprinted X chromosome inactivation in vole Microtus levis.

Alexander I Shevchenko, Elena V Grigor'eva, Sergey P Medvedev, Irina S Zakharova, Elena V Dementyeva, Eugeny A Elisaphenko, Anastasia A Malakhova, Sophia V Pavlova, Suren M Zakian

Abstract read
PubMed Publisher
In one paragraph

Article in Chromosoma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Epigenetic changes during aging and their reprogramming potential.Critical reviews in biochemistry and molecular biology · 2019
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexander I ShevchenkoFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Elena V Grigor'evaFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Sergey P MedvedevFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Irina S ZakharovaFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Elena V DementyevaFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Eugeny A ElisaphenkoFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Anastasia A MalakhovaFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Sophia V PavlovaFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia.
Suren M ZakianFederal Research Centre "Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Prospekt Lavrentyeva, 10, Novosibirsk, 630090, Russia. zakian@bionet.nsc.ru.ORCID 0000-0001-6535-1627
Institute of Cytology and Genetics · RUNovosibirsk State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vole Microtus levis, cells of preimplantation embryo and extraembryonic tissues undergo imprinted X chromosome inactivation (iXCI) which is triggered by a long non-coding nuclear RNA, Xist. At early stages of iXCI, chromatin of vole inactive X chromosome is enriched with the HP1 heterochromatin-specific protein, trimethylated H3K9 and H4K20 attributable to constitutive heterochromatin. In the study, using vole trophoblast stem (TS) cells as a model of iXCI, we further investigated chromatin of the inactive X chromosome of M. levis and tried to find out the role of Xist RNA. We demonstrated that chromatin of the inactive X chromosome in vole TS cells also contained the SETDB1 histone methyltransferase and KAP1 protein. In addition, we observed that Xist RNA did not contribute significantly to maintenance of X chromosome inactive state during iXCI in vole TS cells. Xist repression affected neither transcriptional silencing caused by iXCI nor maintenance of trimethylated H3K9 and H4K20 as well as HP1, KAP1, and SETDB1 on the inactive X chromosome. Moreover, the unique repertoire of chromatin modifications on the inactive X chromosome in vole TS cells could be disrupted by a chemical compound, DZNep, and then restored even in the absence of Xist RNA. However, Xist transcript was necessary for recruitment of an additional repressive histone modification, trimethylated H3K27, to the inactive X chromosome during vole TS cell differentiation.

Indexed as

Gene SilencingGenomic ImprintingRNA, Long NoncodingX Chromosome InactivationAnimalsArvicolinaeChromatinFemaleHistonesPromoter Regions, GeneticSequence DeletionTranscription, GeneticChromatinHistonesRNA, Long NoncodingXIST non-coding RNAHistone modificationsImprinted X chromosome inactivationVoleXist

Identifiers

PMID29151149
OpenAlexW2769935928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.